Related Experiment Video
Updated: Jan 15, 2026

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
N6-Methyladenosine Modification in Vascular Smooth Muscle Disease: A Review
Chengjun Huang1, Xianping Long2, Ranzun Zhao3
1Department of Cardiology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Background:
The impairment of vascular smooth muscle cells (VSMCs) causes many vascular diseases, such as atherosclerosis, hypertension, and heart conditions. Research has shown that N6-methyladenosine (m6A) modification regulates VSMCs' function in a vascular environment.
Summary:
By regulating RNA metabolism, m6A modification affects key biological processes in VSMCs, such as proliferation, migration, phenotypic transformation, and apoptosis. We aim to examine the role of m6A modification and its associated enzymes in vascular diseases caused by VSMC dysfunction and explore its potential as a therapeutic target so that we can develop drugs targeting VSMC dysfunction on a scientific basis.
Key Messages:
m6A modification's role in cardiovascular disorders and potential as a therapeutic target demand further study as a critical regulating component in VSMC biology.
Related Concept Videos
RNA Editing
Atherosclerosis I: Introduction
Regulation of Angiogenesis and Blood Supply
Antihypertensive Drugs: Vasodilators

